Literature DB >> 16787640

Relative effects of mannitol and hypertonic saline on calpain activity, apoptosis and polymorphonuclear infiltration in traumatic focal brain injury.

Jean F Soustiel1, Eugene Vlodavsky, Menashe Zaaroor.   

Abstract

The purpose of this study was to compare the relative effects of mannitol and hypertonic saline (HTS) on calpain activity, apoptosis and neuroinflammatory response induced by experimental cortical contusion. Four groups of 5 Sprague-Dawley male rats were submitted to focal brain injury produced by exposing the parietal cortex to dynamic cortical deformation. Groups were defined by rescucitation fluids administered 30 min post-injury as follows: group 1-0.9% normal saline 2 ml/kg; group 2-mannitol 20% 0.5 g/kg; group 3-HTS 2 ml/kg; group 4-HTS 4 ml/kg. At 72 h, animals were sacrificed. Paraffin-mounted sections of were stained for mu-Calpain, TUNEL, active caspase 3 and myeloperoxidase. There was no difference in the lesion size between the different groups. In contrast, there was a significant reduction in calpain and apoptosis activity and in the neuroinflammatory response in animals receiving HTS. Although mannitol proved to significantly decrease the neuroinflammatory response and calpain activity, it did not affect apoptosis, and its effect was significantly less than that of HTS. Importantly, the effect of HTS was mostly independent from the infused volume. Our results show that HTS promotes cell survival and reduces secondary brain damage following TBI. This protective effect was evidenced at rather small infused volumes, proved to encompass several cellular and molecular mechanisms involved in secondary cell death and could not be related to relief of intracranial pressure. These findings suggest that the high osmolality of HTS may have protective effects besides its impact on brain edema.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787640     DOI: 10.1016/j.brainres.2006.05.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage.

Authors:  David L Schreibman; Caron M Hong; Kaspar Keledjian; Svetlana Ivanova; Solomiya Tsymbalyuk; Volodymyr Gerzanich; J Marc Simard
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

Review 2.  Modern approaches to pediatric brain injury therapy.

Authors:  Peter A Walker; Matthew T Harting; James E Baumgartner; Stephen Fletcher; Nathan Strobel; Charles S Cox
Journal:  J Trauma       Date:  2009-08

Review 3.  Neuroimaging of traumatic brain injury in military personnel: An overview.

Authors:  Avnish Bhattrai; Andrei Irimia; John Darrell Van Horn
Journal:  J Clin Neurosci       Date:  2019-07-19       Impact factor: 1.961

4.  The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat.

Authors:  Andrea Quigley; Arlene A Tan; Michael R Hoane
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

Review 5.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

6.  In vivo leukocyte-mediated brain microcirculatory inflammation: a comparison of osmotherapies and progesterone in severe traumatic brain injury.

Authors:  Kenichiro Kumasaka; Joshua A Marks; Rachel Eisenstadt; Mohammad A Murcy; Davoud Samadi; Shengjie Li; Victoria Johnson; Kevin D Browne; Douglas H Smith; C William Schwab; Jose L Pascual
Journal:  Am J Surg       Date:  2014-09-22       Impact factor: 2.565

7.  Hypertonic Saline Compared to Mannitol for the Management of Elevated Intracranial Pressure in Traumatic Brain Injury: A Meta-Analysis.

Authors:  Chengchen Han; Fan Yang; Shengli Guo; Jianning Zhang
Journal:  Front Surg       Date:  2022-01-07

Review 8.  Inflammatory response following diffuse axonal injury.

Authors:  Yu Lin; Liang Wen
Journal:  Int J Med Sci       Date:  2013-03-13       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.